Get Free Access
TZ Ref No.: TZ-26-1426611
Tender Notice Live Notice National (NCB) Russian Federation Pharmaceuticals

Supply of the medicinal product Blood coagulation factor VIII, lyophilisate for the preparation of a solution for intravenous administration and/or infusion, 500 IU within the framework of the implementation of the Decree of the Government of the Russian Federation of November 26, 2018 No. 1416 “On the procedure for organizing the provision of medicines to persons with hemophilia, cystic fibrosis, pituitary dwarfism, Gaucher disease, malignant neoplasms lymphoid, hematopoietic and related tissue

Doc ref no. 0873•••
Sector Pharmaceuticals
Publish Date 11 Nov 2026
Estimated Value RUB ••••••
Tender Intelligence
Qualification analysis + key highlights for this procurement

TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.

A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.

Sign in to unlock Bid Fit & AI Opportunity Intelligence

TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).

Description & Project Overview

Tenders are invited for Supply of the medicinal product Blood coagulation factor VIII, lyophilisate for the preparation of a solution for intravenous administration and/or infusion, 500 IU within the framework of the implementation of the Decree of the Government of the Russian Federation of November 26, 2018 No. 1416 “On the procedure for organizing the provision of medicines to persons with hemophilia, cystic fibrosis, pituitary dwarfism, Gaucher disease, malignant neoplasms lymphoid, hematopoietic and related tissues, multiple sclerosis, hemolytic-uremic syndrome, juvenile arthritis with systemic onset, mucopolysaccharidosis types I, II and VI, unspecified aplastic anemia, hereditary deficiency of factors II (fibrinogen), VII (labile), X (Stuart-Prower), persons after organ and (or) tissue transplantation, as well as recognition certain acts of the Government of the Russian Federation have become invalid". Procuring entity: ФЕДЕРАЛЬНОЕ КАЗЕННОЕ УЧРЕЖДЕНИЕ "ФЕДЕРАЛЬНЫЙ ЦЕНТР ПЛАНИРОВАНИЯ И ОРГАНИЗАЦИИ ЛЕКАРСТВЕННОГО ОБЕСПЕЧЕНИЯ ГРАЖДАН" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ. Registry Number: 0873400003926000996. Law: 44-ФЗ Запрос котировок в электронной форме.

Days to Deadline
Refer to Document
Closing: Refer to Document
Register to Bid Check Bid Capacity
· · Alert

Consortium & JV Partners

Matched
Need a Co-Bidder or Subcontractor?

Forming a Joint Venture increases technical eligibility and financial bonding capacity.

Post / Find JV Partners →

Key Procurement Details

Doc ref no. 0873•••
Notice Type Tender Notice
Bidding Type NCB
Publish Date 11 Nov 2026
Sector Pharmaceuticals
Bid Security Sign in to view

Buyer Contact Information

Contact Details Locked

Procurement contact email, telephone, and buyer coordinates are unlocked upon starting your 7-Day Free Pro Trial.

Start 7-Day Free Trial →